已发表的文章：
(1) Liu Jing, Wang Tiecheng, Xie Ying, et al. Neutralization Activity of Influenza A Virus Humanized Antibodies against New Subtype Influenza Viruses, Biosafety and Health. 2019, 1(2590-0536): 159-161
(2) Liu Jing, Ren Zhiguang, Wang Hongmei, et al. Influenza virus-like particles composed of conserved influenza proteins and T GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses. International Immunopharmacology. 2018; 16;200:9-18.
(3) Ren Zhiguang, Zhao Yongkun, Liu Jing, et al. Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice. Vaccine. 2018 Sep 25;36(40):5990-5998. (共一)
(4) Ren Zhiguang, Zhao Yongkun, Liu Jing, et al. Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge. International Immunopharmacology.2018 May;58:109-116. (共一)
(5) Zhang Kun, Xu Weiwei, Zhang Zhaowei, Liu Jing, et al. The innate immunity of guinea pigs against highly pathogenic avianinfluenza virus infection. Oncotarget.2017 May 2;8(18):30422 30437.
(6) 刘静, 任志广,王铁成,等. 通用H5N1亚型禽流感病毒样颗粒疫苗的制备[J]. 中国病原生物学杂志, 2019, 014(007):755-760.
